Miami Cancer Institute can provide access to clinical trials not widely available elsewhere. Clinical trials find new ways to treat and diagnose cancer and are ongoing. If an appropriate trial is available, we will talk to you about the benefits and risks.
At Miami Cancer Institute, we understand that the true definition of compassionate care is that nothing is more important than the patient sitting in front of you. We are ready to care for you.
Manuel Ozambela, Jr., M.D., is a urologic surgical oncologist at Baptist Health Miami Cancer Institute. He specializes in the treatment of cancers that arise from the genitourinary system (urinary and reproductive systems), including kidney, bladder, prostate, testicular and penile cancers. He is fluent in English and Spanish.
Prior to joining Baptist Health, Dr. Ozambela completed his fellowship in urologic oncology at the University of Texas MD Anderson Cancer Center. During the fellowship, he worked with a multidisciplinary group of investigators to study rare and aggressive kidney tumors with the goal of identifying novel treatment options. He has authored multiple scientific abstracts, manuscripts and book chapters on various topics in urologic oncology.
Through his research, he strives to identify new diagnostic and treatment options for genitourinary cancers, improve patient recovery after surgery and enhance his patients’ quality of life.
Understanding that he often meets patients during significantly stressful moments, Dr. Ozambela takes time to talk through diagnoses and treatment options. Through excellent communication and shared decision-making, he works with his patients to create treatment plans that reflect their individual goals.
Dr. Ozambela is a South Florida native and enjoys spending time with his growing family when not taking care of patients.
As Florida's only member of the Memorial Sloan Kettering (MSK) Cancer Alliance, Miami Cancer Institute is part of a deep and functional collaboration that affords patients access to innovative treatments right here at home and ensures that the standards of care developed by our multidisciplinary disease management team match those at MSK.